pattrawut-s-shutterstock-com
Pattrawut S / Shutterstock.com
29 June 2015Americas

Eli Lilly wins Alimta appeal at English Court of Appeal

The English Court of Appeal has ruled in favour of Eli Lilly, finding that a patent covering its blockbuster lung drug Alimta (pemetrexed disodium) would be infringed by a product proposed by Actavis, now Allergan.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
15 February 2016   Eli Lilly has lost the latest round of its patent battle with Allergan centring on the lung cancer drug Alimta.

More on this story

Big Pharma
15 February 2016   Eli Lilly has lost the latest round of its patent battle with Allergan centring on the lung cancer drug Alimta.

More on this story

Big Pharma
15 February 2016   Eli Lilly has lost the latest round of its patent battle with Allergan centring on the lung cancer drug Alimta.